Legal Representation
Attorney
Jinggao LI
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 10, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jul 7, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 7, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Mar 22, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 22, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 4, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer; Aloe vera preparations for pharmaceutical purposes; Bismuth preparations for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Potassium preparations for pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording "WUVIKTO" with a design showing gene mutation on the left.
Translation
The wording WUVIKTO has no meaning in a foreign language.
Classification
International Classes
005